GlassScriptPhysician profile
Allman T Rollins
NPI 1205256013
$8,711.57
in general payments reported to CMS, 2019-2025
4 companies · $1,578 in 2025
The $1,578 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $183 · 2021: $160 · 2022: $237 · 2023: $3,657 · 2024: $2,787 · 2025: $1,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,648 · Food and Beverage: $3,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,648.15 |
| Food and Beverage | $3,374.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $5,751.46 | 2023-2025 | Barostim Neo System |
| Abbott Laboratories | $2,639.94 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $252.50 | 2021-2025 | Impella |
| Lexicon Pharmaceuticals, INC. | $67.67 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allman Rollins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.